Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gos...
Target ALS and the Alzheimer' s Drug Discovery Foundation (ADDF) announced today the first four award recipients in a new initiative to identify and develop biomarkers for neurodegenerative diseases [...
The company' s research activities are performed in collaboration with Scuola Internazionale Superiore di Studi Avanzati (SISSA), a scientific center of excellence in Trieste. Read the article...
The international team of Sissa (International School for Advanced Studies), Italy, collaborated with the researchers at the University of California, Los Angeles and the University of Leeds to develo...
Complexities involved in diagnosing and treating epilepsy, seizures, and similar disorders pose a major challenge for healthcare providers. […] Researchers from the Universities of Trieste, Strasbourg...
